Home
About
Medicilon Overview
Executive Team
CEO Message
Corporate Culture
Company History
Honor
Services
Integrated Projects
Antibody-Drug-Antibody (ADC)
Preclinical Research Services
IND Filing
Bio Drug Development
Chemical Drug Development
Chemical Compound Druggability Assessment
Molecular Imaging & Radiochemistry
OINDP Development
Preclinical Ophthalmic Research Platform
Pharmacology Services
Cancer Xenograft Models
Orthotopic Models
Syngeneic Mouse Models
Transgenic Mouse Model
Humanized Mouse Model (hPBMCEngrafted)
PDX Model
Digestive System Models
Neurological Disorders Models
Metabolic Disease Models
Inflammation & Immunological Disease Models
Other Disease Models
Chemistry Services
Medicinal Chemistry Services
Synthetic Chemistry
Process Development Services
Analytical Chemistry
Drug Formulation
Pre Formulation Development
Analytical Development
Formulation Development Services
Generics Consistency Evaluation
Research on Quality Control
Clinical Trial Material
OINDP Development
Biology Services
Discovery Biology Services
Recombinant Protein Services
Computational Biology & Molecular Modeling
Crystallization & Structural Determination
Kinase Services
SeMet Media Sales
Bioanalytical Services
Large Molecule Bioanalysis
Small Molecule Bioanalysis
Pharmacokinetic Services
In Vivo Assays
In Vitro Assays
Drug Safety Evaluation
Inhalation Toxicity Assessment
Customer
Customer Reviews
New Models of Collaboration
Intellectual Property Protection
Download Center
Careers
News
Medicilon Events
Media Coverage
Featured Stories
Contact
Executive Team
Home
Executive Team
Chunlin Chen, Ph.D.
CEO
Guolin Wang, MBA
Board Secretary
Shuangqing Peng Ph.D.
VP of Preclinical
Xiaodong Zhang Ph.D.
VP of Preclinical
Baomin Xin Ph.D.
VP of DMPK & BA
Xingquan Ma Ph.D.
VP of Chemistry
Jinna Cai, Ph.D.
VP, Business Development Dept.
About Us
Medicilon Overview
Executive Team
Company History
CEO Message
Honor
Customer Reviews
New Models of Collaboration
Intellectual Property Protection
Corporate Culture
Careers
Download Center
Contact
Share
Home
About
Medicilon Overview
Executive Team
CEO Message
Corporate Culture
Company History
Honor
Services
Integrated Projects
Antibody-Drug-Antibody (ADC)
Preclinical Research Services
IND Filing
Bio Drug Development
Chemical Drug Development
Chemical Compound Druggability Assessment
Molecular Imaging & Radiochemistry
OINDP Development
Preclinical Ophthalmic Research Platform
Pharmacology Services
Cancer Xenograft Models
Orthotopic Models
Syngeneic Mouse Models
Transgenic Mouse Model
Humanized Mouse Model (hPBMCEngrafted)
PDX Model
Digestive System Models
Neurological Disorders Models
Metabolic Disease Models
Inflammation & Immunological Disease Models
Other Disease Models
Chemistry Services
Medicinal Chemistry Services
Synthetic Chemistry
Process Development Services
Analytical Chemistry
Drug Formulation
Pre Formulation Development
Analytical Development
Formulation Development Services
Generics Consistency Evaluation
Research on Quality Control
Clinical Trial Material
OINDP Development
Biology Services
Discovery Biology Services
Recombinant Protein Services
Computational Biology & Molecular Modeling
Crystallization & Structural Determination
Kinase Services
SeMet Media Sales
Bioanalytical Services
Large Molecule Bioanalysis
Small Molecule Bioanalysis
Pharmacokinetic Services
In Vivo Assays
In Vitro Assays
Drug Safety Evaluation
Inhalation Toxicity Assessment
Customer
Customer Reviews
New Models of Collaboration
Intellectual Property Protection
Download Center
Careers
News
Medicilon Events
Media Coverage
Featured Stories
Contact